Loading...
Please wait, while we are loading the content...
Similar Documents
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Kornej, Jelena Potpara, Tatjana S. |
| Copyright Year | 2013 |
| Abstract | Oral anticoagulant therapy, either with vitamin K antagonists (VKAs) or with novel oral anticoagulants such as dabigatran, rivaroxaban, and apixaban, is the mainstay for thromboprophylaxis in patients with atrial fibrillation (AF). Thromboembolic risk factors associated with AF and risk factors for bleeding associated with oral anticoagulant therapy are largely the same, and bleeding risk very rarely outweighs individual benefit of thrombosis prevention, thus resulting in positive net clinical benefit of oral anticoagulant therapy in almost all AF patients. Prevention of AF‑related thromboembolic events most commonly requires long‑term oral anticoagulant therapy. Over time, various clinical situations may occur in a given patient (e.g., a need for an urgent surgery or invasive intervention, acute stroke, etc.), which may require a temporary or permanent modification of anticoagulant therapy regardless of which anticoagulant drug has been used. This may be particularly challenging for physicians because many issues regarding optimal use of oral anticoagulant drugs in specific clinical situations still remain to be solved. In this review article, we discuss the periprocedural management of oral anticoagulant therapy, bridging, transition to another oral anticoagulant, the occurrence of acute stroke in a patient already taking an oral anticoagulant, and decision when it is safe to resume oral anticoagulation therapy after stroke. We summarize the available evidence and current (and future) approaches to oral anticoagulation management in such clinical situations. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://pamw.pl/sites/default/files/PAMW_2013-11_Lip_1.pdf |
| PubMed reference number | 24104195v1 |
| Volume Number | 123 |
| Issue Number | 11 |
| Journal | Polskie Archiwum Medycyny Wewnetrznej |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Anticoagulants Anticoagulation Therapy Atrial Fibrillation Cerebrovascular accident Ephrin Type-B Receptor 1, human Heart Atrium Hemorrhage Patients Thromboembolism Thrombosis Ventricular Fibrillation Vitamin K antagonists apixaban dabigatran rivaroxaban |
| Content Type | Text |
| Resource Type | Article |
